Cover Image
Market Research Report
Product code 
1100545

Precision Medicine Market Report 2022-2032: Forecasts by Product Type (Diagnostics, Therapeutics), by Application, by End-user, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios

Published: | Visiongain Reports Ltd. | 441 Pages | Delivery time: 1-2 business days

Price

Back to Top
Precision Medicine Market Report 2022-2032: Forecasts by Product Type (Diagnostics, Therapeutics), by Application, by End-user, Regional & Leading National Market Analysis, Leading Companies, and COVID-19 Recovery Scenarios
Published: July 5, 2022
Visiongain Reports Ltd.
Content info: 441 Pages
Delivery time: 1-2 business days
  • Description
  • Table of Contents
  • List of Tables

Title:
Precision Medicine Market Report 2022-2032
Forecasts by Product Type (Diagnostics (Genetic Tests, Biomarker-based Tests, Others), Therapeutics), by Application (Oncology, CNS, Immunology, Respiratory, Others), by End-user (Hospitals, Diagnostic Centres, Research & Academic Institutes, Others) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Recovery Scenarios.

The Precision Medicine Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Global Burden of Cancer, Rising Demand for Targeted Therapy, And Growing Precedence of Precision Medicine Are Driving the Market Growth

Some of the major forces propelling the global precision medicine market include increasing global burden of cancer, rising demand for targeted therapy, and growing precedence of precision medicine. According to Cancer Research UK, an estimated 23.6 million new cases of cancer will be reported in 2030 worldwide which can be attributed to factors such as population growth and rise in geriatric population. Based on these statistics, basic and translational cancer research continues to be of utmost importance.

A better understanding of the genetic characteristics or biomarkers of an individual can promote the practice or administering the right drug, at the right time, at the right dose, for the right person. Implementation of patient-selection diagnostic set-up in the earlier phases of drug development has been the core objective of pharmacological, pharmaceutical and biopharmaceutical firms for which significant efforts are being put so that targeted therapies are delivered to the right candidate which further supplements the growth of the precision medicine market. Furthermore, the increase in scope of application of precision medicine is expected to propel market growth. Precision medicine have numerous application areas, which includes oncology, central nervous system (CNS), immunology, respiratory and other diseases. Several studies are exploring the possibilities of developing diagnostic tests and therapeutics for other cancer indications, such as prostate cancer, ovarian cancer, and leukaemia. New entrants have identified this opportunity to venture into the market by developing tests for rare indications, such as ovarian cancer.

High Cost of Precision Medicine and Insufficient Funding For Diagnostics Space in Developing Countries Can Thwart the Market Growth

Precision medicine may be well-established in pharma industry, however overwhelming cost hinder its reach to payers, patients, and physicians. This high initial cost puts these tests and therapies out of reach of a large portion of end users particularly those in developing countries despite of its benefits and assured returns on investment.

The lack of data interoperability is another key barrier in achieving precision medicines to its full potential. Without international data standards on genomic data, it is not possible to integrate data on genetic markers into patient records that would help researchers to understand why particular set of population is particularly susceptible to a decease. Also, diagnostics has always been perceived as a small step in a healthcare program, and insufficient funding in this space particularly in emerging economies further impedes the market growth.

What Questions Should You Ask before Buying a Market Research Report?

  • How is the Precision Medicine market evolving?
  • What is driving and restraining the Precision Medicine market?
  • How will each Precision Medicine submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032?
  • How will the market shares for each Precision Medicine submarket develop from 2022 to 2032?
  • What will be the main driver for the overall market from 2022 to 2032?
  • Will leading Precision Medicine markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
  • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032?
  • Who are the leading players and what are their prospects over the forecast period?
  • What is the Precision Medicine projects for these leading companies?
  • How will the industry evolve during the period between 2020 and 2032? What are the implications of Precision Medicine projects taking place now and over the next 10 years?
  • Is there a greater need for product commercialisation to further scale the Precision Medicine market?
  • Where is the Precision Medicine market heading and how can you ensure you are at the forefront of the market?
  • What are the best investment options for new product and service lines?
  • What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the Precision Medicine market today, and over the next 10 years:

  • Our 441-page report provides 267 tables and 411 charts/graphs exclusively to you.
  • The report highlights key lucrative areas in the industry so you can target them - NOW.
  • It contains in-depth analysis of global, regional and national sales and growth.
  • It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the Precision Medicine market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2032 and other analyses reveal commercial prospects

  • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares.
  • You will find original analyses, with business outlooks and developments.
  • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising Precision Medicine prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, "V" , "L" , "W" and "U" are discussed in this report.

Segments Covered in the Report:

By Product Type

  • Diagnostics
    • Genetic tests
    • Biomarker based tests
    • Others
  • Therapeutics

By Application

  • Oncology
  • CNS
  • Immunology
  • Respiratory
  • Others

By End User

  • Hospitals
  • Diagnostic centres
  • Research & academic institutes
  • Other end-users

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

  • U.S.
  • Canada
  • Mexico

Europe

  • Germany
  • Spain
  • United Kingdom
  • France
  • Italy
  • Switzerland
  • Rest of Europe

Asia Pacific

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific

LAMEA

  • Brazil
  • Mexico
  • Saudi Arabia
  • Rest of Latin America

The report also includes profiles and for some of the leading companies in the Precision Medicine Market, 2022 to 2032, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

  • Abbott Laboratories
  • Abnova Corporation
  • Agilent Technologies
  • AstraZeneca
  • BioMérieux SA
  • Eli Lilly & Company
  • F Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Illumina
  • Myriad Genetics Inc.
  • Novartis AG
  • Pfizer Inc.
  • Qiagen Inc.
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific, Inc.

Overall world revenue for Precision Medicine Market, 2022 to 2032 in terms of value the market will surpass US$63,333 million in 2021, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Precision Medicine Market, 2022 to 2032 report help you?

In summary, our 440+ page report provides you with the following knowledge:

  • Revenue forecasts to 2032 for Precision Medicine Market, 2022 to 2032 Market, with forecasts for product type, application, and end user and at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
  • Revenue forecasts to 2032 for four regional and 14 key national markets - See forecasts for the Precision Medicine Market, 2022 to 2032 market in North America, Europe, Asia-Pacific and LAMEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, and Japan among other prominent economies.
  • Prospects for established firms and those seeking to enter the market - including company profiles for 20 of the major companies involved in the Precision Medicine Market, 2022 to 2032.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain's study is for everybody needing commercial analyses for the Precision Medicine Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.

Visiongain is a trading partner with the US Federal Government.

Product Code: PHA1178

Table of Contents

1. Report Overview

  • 1.1. Introduction to Global Precision Medicine Market
  • 1.2. Global Precision Medicine Market Definition
  • 1.3. Why You Should Read This Report
  • 1.4. What This Report Delivers
  • 1.5. Key Questions Answered By This Analytical Report Include:
  • 1.6. Who is This Report For?
  • 1.7. Methodology
    • 1.7.1. Primary Research
    • 1.7.2. Secondary Research
    • 1.7.3. Market Evaluation & Forecasting Methodology
  • 1.8. Frequently Asked Questions (FAQs)
  • 1.9. Associated Visiongain Reports
  • 1.10. About Visiongain

2. Executive Summary

3. Qualitative Analysis of the Global Precision Medicine Market

  • 3.1. Market Dynamics
    • 3.1.1. Drivers
      • 3.1.1.1. Increasing global burden of cancer boosts the demand for personalized medicine
      • 3.1.1.2. Increase in scope of application of precision medicine
      • 3.1.1.3. Accelerating demand for targeted therapy
      • 3.1.1.4. Growing precedence of precision medicine over traditional practice of "one-size-fits-all" therapies
    • 3.1.2. Restraints
      • 3.1.2.1. High cost of precision medicine
      • 3.1.2.2. Lack of data interoperability
      • 3.1.2.3. Insufficient funding for diagnostics space in the emerging economies
    • 3.1.3. Opportunity
      • 3.1.3.1. Growing Use of AI in Healthcare Is Boosting Demand for Precision Medicine
      • 3.1.3.2. Growing acceptance of gene therapy and gene editing technology
  • 3.2. PEST Analysis
    • 3.2.1. Political
    • 3.2.2. Economic
    • 3.2.3. Sociocultural
    • 3.2.4. Technological
  • 3.3. Porter's Five Forces Analysis
    • 3.3.1. Moderate Bargaining Power of Supplier
    • 3.3.2. High Bargaining Power of Buyer
    • 3.3.3. Low Threat of New Entrants
    • 3.3.4. High Threat of Substitutes
    • 3.3.5. High Intensity of Competitive Rivalry
  • 3.4. SWOT Analysis
  • 3.5. COVID-19 Impact Analysis
    • 3.5.1. V-Shaped Recovery
    • 3.5.2. U-Shaped Recovery
    • 3.5.3. L-Shaped Recovery
    • 3.5.4. W-Shaped Recovery

4. Global Precision Medicine Market, by Product Type, 2022-2032

  • 4.1. Global Precision Medicine Market Forecast by product type, 2022-2032
  • 4.2. Diagnostics
    • 4.2.1. Global Precision Medicine Market for Diagnostics by Region: Market Forecast, 2022-2032
    • 4.2.2. COVID-19 Impact on Global Precision Medicine Market Forecast for Diagnostics: Recovery Scenarios (V, U, W, L)
    • 4.2.3. Genetic Tests
      • 4.2.3.1. Increased adoption of next-generation DNA sequencing technologies
      • 4.2.3.2. Global Precision Medicine Market for Genetic tests by Region: Market Forecast, 2022-2032
      • 4.2.3.3. COVID-19 Impact on Global Precision Medicine Market Forecast for Genetic tests: Recovery Scenarios (V, U, W, L)
    • 4.2.4. Biomarker Based Tests
      • 4.2.4.1. Global Precision Medicine Market for Biomarker based tests by Region: Market Forecast, 2022-2032
      • 4.2.4.2. COVID-19 Impact on Global Precision Medicine Market Forecast for Biomarker based tests: Recovery Scenarios (V, U, W, L)
    • 4.2.5. Others
      • 4.2.5.1. Global Precision Medicine Market for Others by Region: Market Forecast, 2022-2032
      • 4.2.5.2. COVID-19 Impact on Global Precision Medicine Market Forecast for Others: Recovery Scenarios (V, U, W, L)
  • 4.3. Therapeutics
    • 4.3.1. Rising demand in targeted treatment of different diseases
    • 4.3.2. Global Precision Medicine Market for Therapeutics: Market Forecast, 2022-2032
    • 4.3.3. COVID-19 Impact on Global Precision Medicine Market Forecast for Therapeutics: Recovery Scenarios (V, U, W, L)

5. Global Precision Medicine Market, by Application, 2022-2032

  • 5.1. Global Precision Medicine Market Forecast by Application, 2022-2032
  • 5.2. Oncology
    • 5.2.1. Global Precision Medicine Market for Oncology by Region: Market Forecast, 2022-2032
    • 5.2.2. COVID-19 Impact on Global Precision Medicine Market For Oncology: Recovery Scenarios (V, U, W, L)
  • 5.3. CNS
    • 5.3.1. Increasing use of AI-based precision medicine solutions for neurological disorders
    • 5.3.2. Global Precision Medicine Market for CNS by Region: Market Forecast, 2022-2032
    • 5.3.3. COVID-19 Impact on Global Precision Medicine Market For CNS: Recovery Scenarios (V, U, W, L)
  • 5.4. Immunology
    • 5.4.1. Growing Prevalence of Immunological Diseases
    • 5.4.2. Global Precision Medicine Market for Immunology by Region: Market Forecast, 2022-2032
    • 5.4.3. COVID-19 Impact on Global Precision Medicine Market For Immunology: Recovery Scenarios (V, U, W, L)
  • 5.5. Respiratory
    • 5.5.1. Global Precision Medicine Market for Respiratory by Region: Market Forecast, 2022-2032
    • 5.5.2. COVID-19 Impact on Global Precision Medicine Market For Respiratory: Recovery Scenarios (V, U, W, L)
  • 5.6. Others Application
    • 5.6.1. Global Precision Medicine Market for Other Application by Region: Market Forecast, 2022-2032
    • 5.6.2. COVID-19 Impact on Global Precision Medicine Market for Other Application: Recovery Scenarios (V, U, W, L)

6. Global Precision Medicine Market, by End User, 2022-2032

  • 6.1. Global Precision Medicine Market Forecast by End User, 2022-2032
  • 6.2. Hospitals
    • 6.2.1. Global Precision Medicine Market for Hospitals by Region: Market Forecast, 2022-2032
    • 6.2.2. COVID-19 Impact on Global Precision Medicine Market For Hospitals: Recovery Scenarios (V, U, W, L)
  • 6.3. Diagnostic Centres
    • 6.3.1. Global Precision Medicine Market for Diagnostic Centres by Region: Market Forecast, 2022-2032
    • 6.3.2. COVID-19 Impact on Global Precision Medicine Market For Diagnostic centres: Recovery Scenarios (V, U, W, L)
  • 6.4. Research & academic institutes
    • 6.4.1. Global Precision Medicine Market for Research & academic institutes by Region: Market Forecast, 2022-2032
    • 6.4.2. COVID-19 Impact on Global Precision Medicine Market Research & academic institutes: Recovery Scenarios (V, U, W, L)
  • 6.5. Other End Users
    • 6.5.1. Global Precision Medicine Market for Other End Users by Region: Market Forecast, 2022-2032
    • 6.5.2. COVID-19 Impact on Global Precision Medicine Market For Other End Users: Recovery Scenarios (V, U, W, L)

7. North America Precision Medicine Market, 2022-2032

  • 7.1.1. COVID-19 Impact on North America Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 7.2. North America Precision Medicine Market Forecast, by product type, 2022-2032
    • 7.2.1. North America Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 7.2.2. North America Precision Medicine Market Forecast, by Application, 2022-2032
  • 7.3. North America Precision Medicine Market Forecast, by End User, 2022-2032
  • 7.4. North America Precision Medicine Market Forecast, by Country, 2022-2032
  • 7.5. US
    • 7.5.1. Increased demand for molecular diagnostic-based personalized medicine
    • 7.5.2. Rise in funding for precision medicine
    • 7.5.3. U.S. Precision Medicine Market Forecast, by product type, 2022-2032
    • 7.5.4. US Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 7.5.5. US Precision Medicine Market Forecast, by Application, 2022-2032
    • 7.5.6. US Precision Medicine Market Forecast, by End User, 2022-2032
    • 7.5.7. COVID-19 Impact on US Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 7.6. Canada
    • 7.6.1. Government initiatives to promote precision medicine
    • 7.6.2. Advancement in genomic technology
    • 7.6.3. Canada Precision Medicine Market Forecast, by product type, 2022-2032
    • 7.6.4. Canada Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 7.6.5. Canada Precision Medicine Market Forecast, by Application, 2022-2032
    • 7.6.6. Canada Precision Medicine Market Forecast, by End User, 2022-2032
    • 7.6.7. COVID-19 Impact on Canada Precision Medicine Market: Recovery Scenarios (V, U, W, L)

8. Europe Precision Medicine Market, 2022-2032

  • 8.1.1. COVID-19 Impact on Europe Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 8.2. Europe Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.2.1. Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.2.2. Europe Precision Medicine Market Forecast, by Application, 2022-2032
  • 8.3. Europe Precision Medicine Market Forecast, by End User, 2022-2032
  • 8.4. Europe Precision Medicine Market Forecast, by Country, 2022-2032
  • 8.5. Germany
    • 8.5.1. High healthcare expenditure and partnerships among companies to promote precision medicine solutions
    • 8.5.2. Increased research activities in precision medicine
    • 8.5.3. Germany Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.5.4. Germany Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.5.5. Germany Precision Medicine Market Forecast, by Application, 2022-2032
    • 8.5.6. Germany Precision Medicine Market Forecast, by End User, 2022-2032
    • 8.5.7. COVID-19 Impact on Germany Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 8.6. UK
    • 8.6.1. Increased cancer prevalence and high healthcare expenditure are expected to boost the market
    • 8.6.2. Increasing R&D investments will boost the market
    • 8.6.3. UK Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.6.4. UK Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.6.5. UK Precision Medicine Market Forecast, by Application, 2022-2032
    • 8.6.6. UK Precision Medicine Market Forecast, by End User, 2022-2032
    • 8.6.7. COVID-19 Impact on UK Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 8.7. Switzerland
    • 8.7.1. Key players adopting partnership and acquisition to provide for the increasing demand of precision medicine
    • 8.7.2. Increase in research activities for personalized treatment of cancer
    • 8.7.3. Switzerland Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.7.4. Switzerland Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.7.5. Switzerland Precision Medicine Market Forecast, by Application, 2022-2032
    • 8.7.6. Switzerland Precision Medicine Market Forecast, by End User, 2022-2032
    • 8.7.7. COVID-19 Impact on Switzerland Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 8.8. France
    • 8.8.1. Increasing government funding for genomics and personalized therapeutics R&D is driving market growth in France
    • 8.8.2. Availability of reimbursement for cancer diagnostics
    • 8.8.3. France Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.8.4. France Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.8.5. France Precision Medicine Market Forecast, by Application, 2022-2032
    • 8.8.6. France Precision Medicine Market Forecast, by End User, 2022-2032
    • 8.8.7. COVID-19 Impact on France Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 8.9. Italy
    • 8.9.1. Growing disease prevalence has contributed to the demand for better, more powerful therapeutics in Italy.
    • 8.9.2. Economic slowdown of Italian healthcare industry
    • 8.9.3. Italy Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.9.4. Italy Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.9.5. Italy Precision Medicine Market Forecast, by Application, 2022-2032
    • 8.9.6. Italy Precision Medicine Market Forecast, by End User, 2022-2032
    • 8.9.7. COVID-19 Impact on Italy Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 8.10. Spain
    • 8.10.1. Medical institutes in Spain are increasingly focusing on cancer biomarker research.
    • 8.10.2. Presence of well-established network of research centres and healthcare organization
    • 8.10.3. Spain Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.10.4. Spain Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.10.5. Spain Precision Medicine Market Forecast, by Application, 2022-2032
    • 8.10.6. Spain Precision Medicine Market Forecast, by End User, 2022-2032
    • 8.10.7. COVID-19 Impact on Spain Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 8.11. Rest of Europe
    • 8.11.1. Rest of Europe Precision Medicine Market Forecast, by product type, 2022-2032
    • 8.11.2. Rest of Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 8.11.3. Rest of Europe Precision Medicine Market Forecast, by Application, 2022-2032
    • 8.11.4. Rest of Europe Precision Medicine Market Forecast, by End User, 2022-2032
    • 8.11.5. COVID-19 Impact on Rest of Europe Precision Medicine Market: Recovery Scenarios (V, U, W, L)

9. Asia-Pacific Precision Medicine Market, 2022-2032

  • 9.1.1. COVID-19 Impact on Asia-Pacific Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 9.2. Asia-Pacific Precision Medicine Market Forecast, by product type, 2022-2032
    • 9.2.1. Asia-Pacific Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 9.2.2. Asia-Pacific Precision Medicine Market Forecast, by Application, 2022-2032
  • 9.3. Asia-Pacific Precision Medicine Market Forecast, by End User, 2022-2032
  • 9.4. Asia-Pacific Precision Medicine Market Forecast, by Country, 2022-2032
  • 9.5. Japan
    • 9.5.1. Pharmaceutical companies adopting diverse strategies which is revolutionizing the field of precision oncology in Japan
    • 9.5.2. Japan holds the one of the largest share of the market in APAC majorly due to increasing demand for technologically advanced diagnostics
    • 9.5.3. Japan Precision Medicine Market Forecast, by product type, 2022-2032
    • 9.5.4. Japan Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 9.5.5. Japan Precision Medicine Market Forecast, by Application, 2022-2032
    • 9.5.6. Japan Precision Medicine Market Forecast, by End User, 2022-2032
    • 9.5.7. COVID-19 Impact on Japan Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 9.6. China
    • 9.6.1. The PMI initiative to boost technological capabilities and R&D in the field of genetics and biology
    • 9.6.2. High incidence of chronic diseases
    • 9.6.3. China Precision Medicine Market Forecast, by product type, 2022-2032
    • 9.6.4. China Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 9.6.5. China Precision Medicine Market Forecast, by Application, 2022-2032
    • 9.6.6. China Precision Medicine Market Forecast, by End User, 2022-2032
    • 9.6.7. COVID-19 Impact on China Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 9.7. India
    • 9.7.1. Genome India Project is anticipated to fuel the growth of precision medicine market in India
    • 9.7.2. Presence of large cancer patient
    • 9.7.3. India Precision Medicine Market Forecast, by product type, 2022-2032
    • 9.7.4. India Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 9.7.5. India Precision Medicine Market Forecast, by Application, 2022-2032
    • 9.7.6. India Precision Medicine Market Forecast, by End User, 2022-2032
    • 9.7.7. COVID-19 Impact on India Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 9.8. South Korea
    • 9.8.1. Implementation of diverse strategies by government and private organization have strengthen South Korea's position in precision medicine market
    • 9.8.2. South Korea Precision Medicine Market Forecast, by product type, 2022-2032
    • 9.8.3. South Korea Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 9.8.4. South Korea Precision Medicine Market Forecast, by Application, 2022-2032
    • 9.8.5. South Korea Precision Medicine Market Forecast, by End User, 2022-2032
    • 9.8.6. COVID-19 Impact on South Korea Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 9.9. Rest of APAC
    • 9.9.1. Improvement in R&D and growing demand for targeted therapies has contributed to drive growth of RoAPAC.
    • 9.9.2. Rest of APAC Precision Medicine Market Forecast, by product type, 2022-2032
    • 9.9.3. Rest of APAC Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 9.9.4. Rest of APAC Precision Medicine Market Forecast, by Application, 2022-2032
    • 9.9.5. Rest of APAC Precision Medicine Market Forecast, by End User, 2022-2032
    • 9.9.6. COVID-19 Impact on Rest of APAC Precision Medicine Market: Recovery Scenarios (V, U, W, L)

10. Latin America, Middle East & Africa (LAMEA) Precision Medicine Market, 2022-2032

  • 10.1.1. COVID-19 Impact on LAMEA Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 10.2. LAMEA Precision Medicine Market Forecast, by product type, 2022-2032
    • 10.2.1. LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 10.2.2. LAMEA Precision Medicine Market Forecast, by Application, 2022-2032
  • 10.3. LAMEA Precision Medicine Market Forecast, by End User, 2022-2032
  • 10.4. LAMEA Precision Medicine Market Forecast, by Country, 2022-2032
  • 10.5. Brazil
    • 10.5.1. Increasing initiatives to study genomic supplemented by government funding for R&D activities is anticipated to drive the market
    • 10.5.2. Increase in incidence of chronic disease
    • 10.5.3. Brazil Precision Medicine Market Forecast, by product type, 2022-2032
    • 10.5.4. Brazil Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 10.5.5. Brazil Precision Medicine Market Forecast, by Application, 2022-2032
    • 10.5.6. Brazil Precision Medicine Market Forecast, by End User, 2022-2032
    • 10.5.7. COVID-19 Impact on Brazil Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 10.6. Mexico
    • 10.6.1. Increased Collaboration among private organization as an initiative to offer Personalized Combination Therapy
    • 10.6.2. Growing incidences of cancer and rise in geriatric population
    • 10.6.3. Mexico Precision Medicine Market Forecast, by product type, 2022-2032
    • 10.6.4. Mexico Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 10.6.5. Mexico Precision Medicine Market Forecast, by Application, 2022-2032
    • 10.6.6. Mexico Precision Medicine Market Forecast, by End User, 2022-2032
    • 10.6.7. COVID-19 Impact on Mexico Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 10.7. Saudi Arabia
    • 10.7.1. Growing attention from government for individualized medicine enabled by genomics
    • 10.7.2. Smart health initiative gives healthy boost to precision medicine in Saudi Arabia
    • 10.7.3. Saudi Arabia Precision Medicine Market Forecast, by product type, 2022-2032
    • 10.7.4. Saudi Arabia Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 10.7.5. Saudi Arabia Precision Medicine Market Forecast, by Application, 2022-2032
    • 10.7.6. Saudi Arabia Precision Medicine Market Forecast, by End User, 2022-2032
    • 10.7.7. Saudi Arabia
    • 10.7.8. COVID-19 Impact on Saudi Arabia Precision Medicine Market: Recovery Scenarios (V, U, W, L)
  • 10.8. Rest of LAMEA
    • 10.8.1. Government initiatives to tackle the growing burden of pharmaceutical costs are expected to increase the demand of precision medicine
    • 10.8.2. Rest of LAMEA Precision Medicine Market Forecast, by product type, 2022-2032
    • 10.8.3. Rest of LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032
    • 10.8.4. Rest of LAMEA Precision Medicine Market Forecast, by Application, 2022-2032
    • 10.8.5. Rest of LAMEA Precision Medicine Market Forecast, by End User, 2022-2032
    • 10.8.6. COVID-19 Impact on Rest of LAMEA Precision Medicine Market: Recovery Scenarios (V, U, W, L)

11. Company Profiles

  • 11.1. Pfizer Inc.
    • 11.1.1. Company overview
    • 11.1.2. Company Snapshot
    • 11.1.3. Product Portfolio
    • 11.1.4. Financial Analysis
      • 11.1.4.1. Net Revenue, 2017-2021
      • 11.1.4.2. Segmental Revenue Shares, 2021
      • 11.1.4.3. Regional Revenue Shares, 2021
    • 11.1.5. Recent Developments, 2017-2021
  • 11.2. Qiagen Inc.
    • 11.2.1. Company overview
    • 11.2.2. Company Snapshot
    • 11.2.3. Product Portfolio
    • 11.2.4. Financial Analysis Net Revenue, 2017-2021
      • 11.2.4.1. Segmental Revenue Shares, 2021
      • 11.2.4.2. Regional Revenue Shares, 2021
    • 11.2.5. Recent Developments, 2020-2022
  • 11.3. Quest Diagnostics Inc.
    • 11.3.1. Company Overview
    • 11.3.2. Company Snapshot
    • 11.3.3. Service Portfolio
    • 11.3.4. Financial Analysis
      • 11.3.4.1. Net Revenue, 2017-2021
      • 11.3.4.2. Segmental Revenue Shares, 2021
    • 11.3.5. Recent Developments, 2020-2022
  • 11.4. Agilent Technologies Inc.
    • 11.4.1. Company Overview
    • 11.4.2. Company Snapshot
    • 11.4.3. Product Portfolio
    • 11.4.4. Financial Analysis
      • 11.4.4.1. Net Revenue, 2017-2021
      • 11.4.4.2. Segmental Revenue Shares, 2021
      • 11.4.4.3. Regional Revenue Shares, 2021
    • 11.4.5. Recent Developments, 2017-2021
  • 11.5. Illumina Inc.
    • 11.5.1. Company Overview
    • 11.5.2. Company Snapshot
    • 11.5.3. Product Portfolio
    • 11.5.4. Financial Analysis
      • 11.5.4.1. Net Revenue, 2017-2021
      • 11.5.4.2. Segmental Revenue Shares, 2021
      • 11.5.4.3. Regional Revenue Shares, 2021
    • 11.5.5. Recent Developments, 2017-2021
  • 11.6. Novartis AG
    • 11.6.1. Company Overview
    • 11.6.2. Company Snapshot
    • 11.6.3. Product Portfolio
    • 11.6.4. Financial Analysis
      • 11.6.4.1. Net Revenue, 2017-2021
      • 11.6.4.2. Segmental Revenue Shares, 2021
      • 11.6.4.3. Regional Revenue Shares, 2021
    • 11.6.5. Recent Developments, 2021
  • 11.7. bioMerieux SA
    • 11.7.1. Company Overview
    • 11.7.2. Company Snapshot
    • 11.7.3. Product Portfolio
    • 11.7.4. Financial Analysis
      • 11.7.4.1. Net Revenue, 2017-2021
      • 11.7.4.2. Segmental Revenue Shares, 2021
      • 11.7.4.3. Regional Revenue Shares, 2021
    • 11.7.5. Recent Developments, 2021
  • 11.8. Abbott Laboratories
    • 11.8.1. Company Overview
    • 11.8.2. Company Snapshot
    • 11.8.3. Product Portfolio
    • 11.8.4. Financial Analysis
      • 11.8.4.1. Net Revenue, 2017-2021
      • 11.8.4.2. Segmental Revenue Shares, 2021
      • 11.8.4.3. Regional Revenue Shares, 2021
    • 11.8.5. Recent Developments, 2017-2019
  • 11.9. F Hoffmann La Roche AG
    • 11.9.1. Company Overview
    • 11.9.2. Company Snapshot
    • 11.9.3. Product Portfolio
    • 11.9.4. Financial Analysis
      • 11.9.4.1. Net Revenue, 2017-2021
      • 11.9.4.2. Segmental Revenue Shares, 2021
      • 11.9.4.3. Regional Revenue Shares, 2021
    • 11.9.5. Recent Developments, 2020
  • 11.10. Eli Lilly and Company
    • 11.10.1. Company Overview
    • 11.10.2. Company Snapshot
    • 11.10.3. Product Portfolio
    • 11.10.4. Financial Analysis
      • 11.10.4.1. Net Revenue, 2017-2021
      • 11.10.4.2. Regional Revenue Shares, 2021
    • 11.10.5. Recent Developments, 2017-2020
  • 11.11. GlaxoSmithKline Plc.
    • 11.11.1. Company Overview
    • 11.11.2. Company Snapshot
    • 11.11.3. Product Portfolio
      • 11.11.3.1. Net Revenue, 2017-2021
      • 11.11.3.2. Segmental Revenue Shares, 2021
      • 11.11.3.3. Regional Revenue Shares, 2021
    • 11.11.4. Recent Developments, 2019-2022
  • 11.12. AstraZeneca Plc
    • 11.12.1. Company Overview
    • 11.12.2. Company Snapshot
    • 11.12.3. Product Portfolio
    • 11.12.4. Financial Analysis
      • 11.12.4.1. Net Revenue, 2017-2021
      • 11.12.4.2. Segmental Revenue Shares, 2021
      • 11.12.4.3. Regional Revenue Shares, 2021
    • 11.12.5. Recent Developments, 2019-2022
  • 11.13. Thermo Fischer Scientific Inc.
    • 11.13.1. Company Overview
    • 11.13.2. Company Snapshot
    • 11.13.3. Product Portfolio
    • 11.13.4. Financial Analysis
      • 11.13.4.1. Net Revenue, 2017-2021
      • 11.13.4.2. Segmental Revenue Shares, 2021
      • 11.13.4.3. Regional Revenue Shares, 2021
    • 11.13.5. Recent Developments, 2018-2021
  • 11.14. Myriad Genetics Inc.
    • 11.14.1. Company Overview
    • 11.14.2. Company Snapshot
    • 11.14.3. Product Portfolio
    • 11.14.4. Financial Analysis
      • 11.14.4.1. Net Revenue, 2017-2021
      • 11.14.4.2. Segmental Revenue Shares, 2021
    • 11.14.5. Recent Developments, 2020-2021
  • 11.15. Abnova Corporation
    • 11.15.1. Company Overview
    • 11.15.2. Company Snapshot
    • 11.15.3. Product Portfolio
    • 11.15.4. Recent Developments

12. Conclusion and Recommendations

  • 12.1. Concluding Remarks from Visiongain
  • 12.2. Recommendations for Market Players

List of Tables

  • Table 1: Global Precision Medicine Market Snapshot, 2022 & 2032 (US$ million, CAGR %)
  • Table 2: Moderate Bargaining Power of Supplier
  • Table 3: High Bargaining Power of Buyer
  • Table 4: Low Threat of New Entrants
  • Table 5: Low Threat of Substitutes
  • Table 6: High Intensity Of Competitive Rivalry
  • Table 7: Global Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 8: Global Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 9: Global Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 10: Global Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 11: Global Precision Medicine Market Forecast by product type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 12: Global Precision Medicine Market Forecast For Diagnostics by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 13: Global Precision Medicine Market Forecast For Diagnostics, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 14: Global Precision Medicine Market Forecast For Diagnostics, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 15: Global Precision Medicine Market Forecast for Diagnostics, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 16: Global Precision Medicine Market Forecast for Diagnostics, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 17: Global Precision Medicine Market Forecast For Genetic tests by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 18: Global Precision Medicine Market Forecast For Genetic tests, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 19: Global Precision Medicine Market Forecast for Genetic tests, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 20: Global Precision Medicine Market Forecast for Genetic tests, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 21: Global Precision Medicine Market Forecast for Genetic tests, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 22: Global Precision Medicine Market Forecast For Biomarker based tests by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 23: Global Precision Medicine Market Forecast For Biomarker based tests, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 24: Global Precision Medicine Market Forecast for Biomarker based tests, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 25: Global Precision Medicine Market Forecast for Biomarker based tests, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 26: Global Precision Medicine Market Forecast for Biomarker based tests, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 27: Global Precision Medicine Market Forecast For Others by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 28: Global Precision Medicine Market Forecast For Others, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 29: Global Precision Medicine Market Forecast for Others, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 30: Global Precision Medicine Market Forecast for Others, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 31: Global Precision Medicine Market Forecast for Others, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 32: Global Precision Medicine Market Forecast For Therapeutics, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 33: Global Precision Medicine Market Forecast For Therapeutics, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 34: Global Precision Medicine Market Forecast for Therapeutics, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 35: Global Precision Medicine Market Forecast for Therapeutics, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 36: Global Precision Medicine Market Forecast for Therapeutics, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 37: Global Precision Medicine Market Forecast by Application, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 38: Global Precision Medicine Market Forecast For Oncology, by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 39: Global Precision Medicine Market Forecast for Oncology by Region 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 40: Global Precision Medicine Market Forecast for Oncology, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 41: Global Precision Medicine Market Forecast for Oncology, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 42: Global Precision Medicine Market Forecast for Oncology, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 43: Global Precision Medicine Market Forecast For CNS by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 44: Global Precision Medicine Market Forecast for CNS, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 45: Global Precision Medicine Market Forecast for CNS, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 46: Global Precision Medicine Market Forecast for CNS, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 47: Global Precision Medicine Market Forecast for CNS, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 48: Global Precision Medicine Market Forecast For Immunology by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 49: Global Precision Medicine Market Forecast For Immunology, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 50: Global Precision Medicine Market Forecast For Immunology 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 51: Global Precision Medicine Market Forecast for Immunology, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 52: Global Precision Medicine Market Forecast for Immunology, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 53: Global Precision Medicine Market Forecast For Respiratory by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 54: Global Precision Medicine Market Forecast For Respiratory, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 55: Global Precision Medicine Market Forecast For Respiratory, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 56: Global Precision Medicine Market Forecast for Respiratory, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 57: Global Precision Medicine Market Forecast for Respiratory, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 58: Global Precision Medicine Market Forecast For Other Application by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 59: Global Precision Medicine Market Forecast For Other Application, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 60: Global Precision Medicine Market Forecast For Other Application, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 61: Global Precision Medicine Market Forecast for Other Application, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 62: Global Precision Medicine Market Forecast for Other Application, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 63: Global Precision Medicine Market Forecast by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 64: Global Precision Medicine Market Forecast For Hospitals by Region, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 65: Global Precision Medicine Market Forecast for Hospitals (PCR), 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 66: Global Precision Medicine Market Forecast for Hospitals, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 67: Global Precision Medicine Market Forecast for Hospitals, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 68: Global Precision Medicine Market Forecast for Hospitals, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 69: Global Precision Medicine Market Forecast For Diagnostic centres by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 70: Global Precision Medicine Market Forecast for Diagnostic centres, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 71: Global Precision Medicine Market Forecast for Diagnostic centres, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 72: Global Precision Medicine Market Forecast for Diagnostic centres, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 73: Global Precision Medicine Market Forecast for Diagnostic centres, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 74: Global Precision Medicine Market Forecast For Research & academic institutes by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 75: Global Precision Medicine Market Forecast For Research & academic institutes, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 76: Global Precision Medicine Market Forecast For Research & academic institutes, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 77: Global Precision Medicine Market Forecast for Research & academic institutes, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 78: Global Precision Medicine Market Forecast for Research & academic institutes, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 79: Global Precision Medicine Market Forecast For Other End Users by Region, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 80: Global Precision Medicine Market Forecast For Other End Users, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 81: Global Precision Medicine Market Forecast For Other End Users, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 82: Global Precision Medicine Market Forecast for Other End Users, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 83: Global Precision Medicine Market Forecast for Other End Users, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 84: North America Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR
  • Table 85: North America Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 86: North America Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 87: North America Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 88: North America Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 89: North America Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 90: North America Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 91: North America Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 92: North America Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 93: North America Precision Medicine Market Forecast, by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 94: US Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 95: US Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 96: US Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 97: US Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 98: US Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 99: US Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 100: US Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 101: US Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 102: Canada Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 103: Canada Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 104: Canada Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 105: Canada Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 106: Canada Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 107: Canada Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 108: Canada Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 109: Canada Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 110: Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR
  • Table 111: Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 112: Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 113: Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 114: Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 115: Europe Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 116: Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 117: Europe Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 118: Europe Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 119: Europe Precision Medicine Market Forecast, by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 120: Germany Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 121: Germany Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 122: Germany Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 123: Germany Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 124: Germany Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 125: Germany Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 126: Germany Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 127: Germany Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 128: UK Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 129: UK Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 130: UK Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 131: UK Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 132: UK Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 133: UK Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 134: UK Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 135: UK Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 136: Switzerland Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 137: Switzerland Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 138: Switzerland Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 139: Switzerland Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 140: Switzerland Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 141: Switzerland Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 142: Switzerland Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 143: Switzerland Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 144: France Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 145: France Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 146: France Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 147: France Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 148: France Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 149: France Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 150: France Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 151: France Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 152: Italy Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 153: Italy Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 154: Italy Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 155: Italy Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 156: Italy Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 157: Italy Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 158: Italy Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 159: Italy Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 160: Spain Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 161: Spain Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 162: Spain Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 163: Spain Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 164: Spain Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 165: Spain Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 166: Spain Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 167: Spain Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 168: Rest of Europe Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 169: Rest of Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 170: Rest of Europe Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 171: Rest of Europe Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 172: Rest of Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 173: Rest of Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 174: Rest of Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 175: Rest of Europe Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 176: Asia-Pacific Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR
  • Table 177: Asia-Pacific Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 178: Asia-Pacific Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 179: Asia-Pacific Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 180: Asia-Pacific Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 181: Asia-Pacific Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 182: Asia-Pacific Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 183: Asia-Pacific Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 184: Asia-Pacific Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 185: Asia-Pacific Precision Medicine Market Forecast, by Country, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 186: Japan Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 187: Japan Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 188: Japan Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 189: Japan Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 190: Japan Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 191: Japan Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 192: Japan Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 193: Japan Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 194: China Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 195: China Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 196: China Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 197: China Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 198: China Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 199: China Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 200: China Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 201: China Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 202: India Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 203: India Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 204: India Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 205: India Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 206: India Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 207: India Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 208: India Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 209: India Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 210: South Korea Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 211: South Korea Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR %)
  • Table 212: South Korea Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 213: South Korea Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 214: South Korea Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 215: South Korea Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 216: South Korea Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 217: South Korea Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 218: Rest of APAC Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 219: Rest of APAC Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 220: Rest of APAC Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 221: Rest of APAC Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 222: Rest of APAC Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 223: Rest of APAC Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 224: Rest of APAC Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 225: Rest of APAC Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 226: LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR
  • Table 227: LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Table 228: LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): U-Shaped Recovery
  • Table 229: LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): L-Shaped Recovery
  • Table 230: LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): W-Shaped Recovery
  • Table 231: LAMEA Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 232: LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 233: LAMEA Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 234: LAMEA Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 235: LAMEA Precision Medicine Market Forecast, by Country, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 236: Brazil Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 237: Brazil Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 238: Brazil Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 239: Brazil Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 240: Brazil Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 241: Brazil Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 242: Brazil Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 243: Brazil Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 244: Mexico Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 245: Mexico Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 246: Mexico Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 247: Mexico Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 248: Mexico Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 249: Mexico Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 250: Mexico Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 251: Mexico Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 252: Saudi Arabia Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 253: Saudi Arabia Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 254: Saudi Arabia Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 255: Saudi Arabia Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 256: Saudi Arabia Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 257: Saudi Arabia Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 258: Saudi Arabia Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 259: Saudi Arabia Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery
  • Table 260: Rest of LAMEA Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 261: Rest of LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 262: Rest of LAMEA Precision Medicine Market Forecast, by Application, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 263: Rest of LAMEA Precision Medicine Market Forecast, by End User, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Table 264: Rest of LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "V" Shaped Recovery
  • Table 265: Rest of LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "U" Shaped Recovery
  • Table 266: Rest of LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "L" Shaped Recovery
  • Table 267: Rest of LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ Mn, AGR%, CAGR%): "W" Shaped Recovery

List of Figures

  • Figure 1: Global Precision Medicine Market: Market Trends
  • Figure 2: Global Precision Medicine Market: SWOT Analysis
  • Figure 3: COVID-19 Impact on Precision Medicine Market (USD Billion), 2022-2032: V-Shaped Recovery
  • Figure 4: COVID-19 Impact on Precision Medicine Market (USD Billion), 2022-2032: U-Shaped Recovery
  • Figure 5: COVID-19 Impact on Precision Medicine Market (USD Billion), 2022-2032: L-Shaped Recovery
  • Figure 6: COVID-19 Impact on Precision Medicine Market (USD Billion), 2022-2032: W-Shaped Recovery
  • Figure 7: Global Precision Medicine Market Forecast by product type, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 8: Global Precision Medicine Market Share Forecast by product type, 2022, 2027, 2032 (%)
  • Figure 9: Global Precision Medicine Market Share For Diagnostics, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 10: Global Precision Medicine Market Share For Diagnostics, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 11: Global Precision Medicine Market Forecast For Diagnostics, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Figure 12: COVID-19 Impact on Precision Medicine Market for Diagnostics (USD million), 2022-2032: U-Shaped Recovery
  • Figure 13: COVID-19 Impact on Precision Medicine Market for Diagnostics (USD million), 2022-2032: L-Shaped Recovery
  • Figure 14: COVID-19 Impact on Precision Medicine Market for Diagnostics (USD million), 2022-2032: W-Shaped Recovery
  • Figure 15: Global Precision Medicine Market Share For Genetic tests, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 16: Global Precision Medicine Market Share for Genetic tests, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 17: Global Precision Medicine Market Forecast For Genetic tests, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Figure 18: COVID-19 Impact on Precision Medicine Market for Genetic tests (USD million), 2022-2032: U-Shaped Recovery
  • Figure 19: COVID-19 Impact on Precision Medicine Market for Genetic tests (USD million), 2022-2032: L-Shaped Recovery
  • Figure 20: COVID-19 Impact on Precision Medicine Market for Genetic tests (USD million), 2022-2032: W-Shaped Recovery
  • Figure 21: Global Precision Medicine Market Share for Biomarker based tests, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 22: Global Precision Medicine Market Share For Biomarker based tests, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 23: Global Precision Medicine Market Forecast For Biomarker based tests, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Figure 24: COVID-19 Impact on Precision Medicine Market for Biomarker based tests (USD million), 2022-2032: U-Shaped Recovery
  • Figure 25: COVID-19 Impact on Precision Medicine Market for Biomarker based tests (USD million), 2022-2032: L-Shaped Recovery
  • Figure 26: COVID-19 Impact on Precision Medicine Market for Biomarker based tests (USD million), 2022-2032: W-Shaped Recovery
  • Figure 27: Global Precision Medicine Market Share For Others, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 28: Global Precision Medicine Market Share For Others, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 29: Global Precision Medicine Market Forecast For Others, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Figure 31: COVID-19 Impact on Precision Medicine Market for Others (USD million), 2022-2032: L-Shaped Recovery
  • Figure 32: COVID-19 Impact on Precision Medicine Market for Others (USD million), 2022-2032: W-Shaped Recovery
  • Figure 33: Global Precision Medicine Market Share For Therapeutics, Forecast by Region, 2021- 2032
  • Figure 34: Global Precision Medicine Market Share For Therapeutics, Forecast by Region, 2022, 2027, 2032 (%)
  • Figure 35: Global Precision Medicine Market Forecast For Therapeutics, 2022-2032 (US$ Mn, AGR%, CAGR%): V-Shaped Recovery
  • Figure 36: COVID-19 Impact on Precision Medicine Market for Therapeutics, (USD million), 2022-2032: U-Shaped Recovery
  • Figure 37: COVID-19 Impact on Precision Medicine Market for Therapeutics, (USD million), 2022-2032: L-Shaped Recovery
  • Figure 38: COVID-19 Impact on Precision Medicine Market for Therapeutics, (USD million), 2022-2032: W-Shaped Recovery
  • Figure 39: Global Precision Medicine Market, Forecast by Application, 2022- 2032 (US$ Mn)
  • Figure 40: Global Precision Medicine Market Share Forecast by Application, 2022, 2027, 2032 (%)
  • Figure 41: Global Precision Medicine Market Share For Oncology, Forecast by Region, 2022- 2032 (US$ Mn)
  • Figure 42: Global Precision Medicine Market Share Forecast For Oncology by Region, 2022, 2027, 2032 (%)
  • Figure 43: COVID-19 Impact on Precision Medicine Market for Oncology (USD million), 2022-2032: V-Shaped Recovery
  • Figure 44: COVID-19 Impact on Precision Medicine Market for Oncology (USD million), 2022-2032: U-Shaped Recovery
  • Figure 45: COVID-19 Impact on Precision Medicine Market for Big Pharmaceutical Companies (USD million), 2022-2032: L-Shaped Recovery
  • Figure 46: COVID-19 Impact on Precision Medicine Market for Oncology (USD million), 2022-2032: W-Shaped Recovery
  • Figure 47: Global Precision Medicine Market Share For CNS, Forecast by Region, 2022- 2032 (US$ Mn)
  • Figure 48: Global Precision Medicine Market Share Forecast For CNS by Region, 2022, 2027, 2032 (%)
  • Figure 49: COVID-19 Impact on Precision Medicine Market for CNS (USD million), 2022-2032: V-Shaped Recovery
  • Figure 50: COVID-19 Impact on Precision Medicine Market CNS (USD million), 2022-2032: U-Shaped Recovery
  • Figure 51: COVID-19 Impact on Precision Medicine Market for CNS (USD million), 2022-2032: L-Shaped Recovery
  • Figure 52: COVID-19 Impact on Precision Medicine Market for CNS (USD million), 2022-2032: W-Shaped Recovery
  • Figure 53: Global Precision Medicine Market Share For Immunology, 2022- 2032 (US$ Mn)
  • Figure 54: Global Precision Medicine Market Share Forecast For Immunology by Region, 2022, 2027, 2032 (%)
  • Figure 55: COVID-19 Impact on Precision Medicine Market For Immunology (US million), 2022-2032: V-Shaped Recovery
  • Figure 56: COVID-19 Impact on Precision Medicine Market For Immunology (USD million), 2022-2032: U-Shaped Recovery
  • Figure 57: COVID-19 Impact on Precision Medicine Market for Immunology (USD million), 2022-2032: L-Shaped Recovery
  • Figure 58: COVID-19 Impact on Precision Medicine Market for Immunology (USD million), 2022-2032: W-Shaped Recovery
  • Figure 59: Global Precision Medicine Market Share For Respiratory by Region, 2022- 2032 (US$ Mn)
  • Figure 60: Global Precision Medicine Market Share Forecast For Respiratory by Region, 2022, 2027, 2032 (%)
  • Figure 61: COVID-19 Impact on Precision Medicine Market For Respiratory (USD million), 2022-2032: V-Shaped Recovery
  • Figure 62: COVID-19 Impact on Precision Medicine Market For Respiratory (USD million), 2022-2032: U-Shaped Recovery
  • Figure 63: COVID-19 Impact on Precision Medicine Market for Respiratory (USD million), 2022-2032: L-Shaped Recovery
  • Figure 64: COVID-19 Impact on Precision Medicine Market for Respiratory (US million), 2022-2032: W-Shaped Recovery
  • Figure 65: Global Precision Medicine Market Share For Other Application by Region, 2022-2032 (US$ Mn)
  • Figure 66: Global Precision Medicine Market Share Forecast For Other Application by Region, 2022, 2027, 2032 (%)
  • Figure 67: COVID-19 Impact on Precision Medicine Market For Other Application (USD million), 2022-2032: V-Shaped Recovery
  • Figure 68: COVID-19 Impact on Precision Medicine Market For Other Application (USD million), 2022-2032: U-Shaped Recovery
  • Figure 69: COVID-19 Impact on Precision Medicine Market for Other Application (USD million), 2022-2032: L-Shaped Recovery
  • Figure 70: COVID-19 Impact on Precision Medicine Market for Other Application (US million), 2022-2032: W-Shaped Recovery
  • Figure 71: Global Precision Medicine Market, Forecast by End User, 2022- 2032 (US$ Mn)
  • Figure 72: Global Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 73: Global Precision Medicine Market Share For Hospitals, Forecast by Region, 2022- 2032 (US$ Mn)
  • Figure 74: Global Precision Medicine Market Share Forecast For Hospitals by Region, 2022, 2027, 2032 (%)
  • Figure 75: COVID-19 Impact on Precision Medicine Market for Hospitals (USD million), 2022-2032: V-Shaped Recovery
  • Figure 76: COVID-19 Impact on Precision Medicine Market for Hospitals (USD million), 2022-2032: U-Shaped Recovery
  • Figure 77: COVID-19 Impact on Precision Medicine Market for Hospitals (USD million), 2022-2032: L-Shaped Recovery
  • Figure 78: COVID-19 Impact on Precision Medicine Market for Hospitals (USD million), 2022-2032: W-Shaped Recovery
  • Figure 79: Global Precision Medicine Market Share For Diagnostic centers, Forecast by Region, 2022- 2032 (US$ Mn)
  • Figure 80: Global Precision Medicine Market Share Forecast For Diagnostic centers by Region, 2022, 2027, 2032 (%)
  • Figure 81: COVID-19 Impact on Precision Medicine Market for Diagnostic centers (USD million), 2022-2032: V-Shaped Recovery
  • Figure 82: COVID-19 Impact on Precision Medicine Market For Diagnostic centers (USD million), 2022-2032: U-Shaped Recovery
  • Figure 83: COVID-19 Impact on Precision Medicine Market for Diagnostic centers (USD million), 2022-2032: L-Shaped Recovery
  • Figure 84: COVID-19 Impact on Precision Medicine Market for Diagnostic centers (USD million), 2022-2032: W-Shaped Recovery
  • Figure 85: Global Precision Medicine Market Share For Research & academic institutes by Region, 2022- 2032 (US$ Mn)
  • Figure 86: Global Precision Medicine Market Share Forecast For Research & academic institutes by Region, 2022, 2027, 2032 (%)
  • Figure 87: COVID-19 Impact on Precision Medicine Market For Research & academic institutes (US million), 2022-2032: V-Shaped Recovery
  • Figure 88: COVID-19 Impact on Precision Medicine Market For Research & academic institutes (USD million), 2022-2032: U-Shaped Recovery
  • Figure 89: COVID-19 Impact on Precision Medicine Market for Research & academic institutes (USD million), 2022-2032: L-Shaped Recovery
  • Figure 90: COVID-19 Impact on Precision Medicine Market for Research & academic institutes (USD million), 2022-2032: W-Shaped Recovery
  • Figure 91: Global Precision Medicine Market Share For Other End Users by Region, 2022-2032 (US$ Mn)
  • Figure 92: Global Precision Medicine Market Share Forecast For Other End Users by Region, 2022, 2027, 2032 (%)
  • Figure 93: COVID-19 Impact on Precision Medicine Market For Other End Users (USD million), 2022-2032: V-Shaped Recovery
  • Figure 94: COVID-19 Impact on Precision Medicine Market For Other End Users (USD million), 2022-2032: U-Shaped Recovery
  • Figure 95: COVID-19 Impact on Precision Medicine Market for Other End Users (USD million), 2022-2032: L-Shaped Recovery
  • Figure 96: COVID-19 Impact on Precision Medicine Market for Other End Users (US million), 2022-2032: W-Shaped Recovery
  • Figure 97: North America Precision Medicine Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 98: COVID-19 Impact on North America Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 99: COVID-19 Impact on North America Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 10: COVID-19 Impact on North America Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 101: COVID-19 Impact on North America Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 103: North America Precision Medicine Market Share Forecast, by Product& Services, 2022, 2027 and 2032 (%)
  • Figure 105: North America Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 107: North America Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 109: North America Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 111: North America Precision Medicine Market Share Forecast by Country, 2022, 2027, 2032 (%)
  • Figure 113: US Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 115: US Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 117: US Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 118: US Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 119: US Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 120: COVID-19 Impact on US Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 121: COVID-19 Impact on US Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 122: COVID-19 Impact on US Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 123: COVID-19 Impact on US Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 124: Canada Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Figure 125: Canada Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 126: Canada Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 127: Canada Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 129: Canada Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 130: Canada Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 131: Canada Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 132: COVID-19 Impact on Canada Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 133: COVID-19 Impact on Canada Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 134: COVID-19 Impact on Canada Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 135: COVID-19 Impact on Canada Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 136: Europe Precision Medicine Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 137: COVID-19 Impact on Europe Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 138: COVID-19 Impact on Europe Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 139: COVID-19 Impact on Europe Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 140: COVID-19 Impact on Europe Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 141: Europe Precision Medicine Market Share Forecast, by Products & Services, 2022- 2032 (US$ Mn)
  • Figure 142: Europe Precision Medicine Market Share Forecast, by Product& Services, 2021 and 2032 (%)
  • Figure 143: Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 144: Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 145: Europe Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 146: Europe Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 147: Europe Precision Medicine Market Share Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 148: Europe Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 149: Europe Precision Medicine Market Share Forecast, by Country, 2022- 2032 (US$ Mn)
  • Figure 150: Europe Precision Medicine Market Share Forecast by Country, 2022, 2027, 2032 (%)
  • Figure 151: Germany Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Figure 152: Germany Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 153: Germany Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 154: Germany Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 155: Germany Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 156: Germany Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 157: Germany Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 158: Germany Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 159: COVID-19 Impact on Germany Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 160: COVID-19 Impact on Germany Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 161: COVID-19 Impact on Germany Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 162: COVID-19 Impact on Germany Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 163: UK Precision Medicine Market Forecast, by product type, 2022-2032 (US$ Mn, AGR%, CAGR%)
  • Figure 164: UK Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 165: UK Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 166: UK Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 167: UK Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 168: UK Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 169: UK Precision Medicine Market Forecast, by End Users, 2022- 2032 (US$ Mn)
  • Figure 170: UK Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 171: COVID-19 Impact on UK Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 172: COVID-19 Impact on UK Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 173: COVID-19 Impact on UK Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 174: COVID-19 Impact on UK Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 175: Switzerland Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 176: Switzerland Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 177: Switzerland Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 178: Switzerland Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 179: Switzerland Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 180: Switzerland Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 181: Switzerland Precision Medicine Market Forecast, by End Users, 2022- 2032 (US$ Mn)
  • Figure 182: Switzerland Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 183: COVID-19 Impact on Switzerland Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 184: COVID-19 Impact on Switzerland Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 185: COVID-19 Impact on Switzerland Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 186: COVID-19 Impact on Switzerland Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 187: France Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 188: France Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 189: France Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 190: France Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 191: France Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 192: France Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 193: France Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 194: France Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 195: COVID-19 Impact on France Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 196: COVID-19 Impact on France Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 197: COVID-19 Impact on France Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 198: COVID-19 Impact on France Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 199: Italy Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 200: Italy Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 201: Italy Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 202: Italy Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 203: Italy Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 204: Italy Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 205: Italy Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 206: Italy Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 207: COVID-19 Impact on Italy Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 208: COVID-19 Impact on Italy Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 209: COVID-19 Impact on Italy Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 210: COVID-19 Impact on Italy Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 211: Spain Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 212: Spain Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 213: Spain Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 214: Spain Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 215: Spain Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 216: Spain Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 217: Spain Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 218: Spain Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 219: COVID-19 Impact on Spain Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 220: COVID-19 Impact on Spain Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 221: COVID-19 Impact on Spain Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 222: COVID-19 Impact on Spain Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 223: Rest of Europe Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 224: Rest of Europe Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 225: Rest of Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 226: Rest of Europe Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 227: Rest of Europe Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 228: Rest of Europe Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 229: Rest of Europe Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 230: Rest of Europe Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 231: COVID-19 Impact on Rest of Europe Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 232: COVID-19 Impact on Rest of Europe Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 233: COVID-19 Impact on Rest of Europe Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 234: COVID-19 Impact on Rest of Europe Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 235: Asia-Pacific Precision Medicine Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 236: COVID-19 Impact on Asia-Pacific Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 237: COVID-19 Impact on Asia-Pacific Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 238: COVID-19 Impact on Asia-Pacific Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 239: COVID-19 Impact on Asia-Pacific Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 240: Asia-Pacific Precision Medicine Market Share Forecast, by Product& Services, 2022- 2032 (US$ Mn)
  • Figure 241: Asia-Pacific Precision Medicine Market Share Forecast, by Product& Services, 2022, 2027 and 2032 (%)
  • Figure 242: Asia-Pacific Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 243: Asia-Pacific Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032(%)
  • Figure 244: Asia-Pacific Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 245: Asia-Pacific Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 246: Asia-Pacific Precision Medicine Market Share Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 247: Asia-Pacific Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 248: Asia-Pacific Precision Medicine Market Share Forecast, by Country, 2022- 2032 (US$ Mn)
  • Figure 249: Asia-Pacific Precision Medicine Market Share Forecast by Country, 2022, 2027, 2032 (%)
  • Figure 250: Japan Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 251: Japan Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 252: Japan Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 253: Japan Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 254: Japan Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 255: Japan Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 256: Japan Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 257: Japan Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 258: COVID-19 Impact on Japan Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 259: COVID-19 Impact on Japan Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 260: COVID-19 Impact on Japan Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 261: COVID-19 Impact on Japan Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 262: China Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 263: China Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032(%)
  • Figure 264: China Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 265: China Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 266: China Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 267: China Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 268: China Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 269: China Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 270: COVID-19 Impact on China Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 271: COVID-19 Impact on China Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 272: COVID-19 Impact on China Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 273: COVID-19 Impact on China Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 274: India Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 275: India Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032(%)
  • Figure 276: India Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 277: India Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 278: India Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 279: India Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 280: India Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 281: India Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 282: COVID-19 Impact on India Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 283: COVID-19 Impact on India Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 284: COVID-19 Impact on India Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 285: COVID-19 Impact on India Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 286: South Korea Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 287: South Korea Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 288: South Korea Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 289: South Korea Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 290: South Korea Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 291: South Korea Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 292: South Korea Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 293: South Korea Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 294: COVID-19 Impact on South Korea Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 295: COVID-19 Impact on South Korea Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 296: COVID-19 Impact on South Korea Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 297: COVID-19 Impact on South Korea Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 298: Rest of APAC Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 299: Rest of APAC Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 300: Rest of APAC Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 301: Rest of APAC Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 302: Rest of APAC Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 303: Rest of APAC Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 304: Rest of APAC Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 305: Rest of APAC Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 306: COVID-19 Impact on Rest of APAC Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 307: COVID-19 Impact on Rest of APAC Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 308: COVID-19 Impact on Rest of APAC Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 309: COVID-19 Impact on Rest of APAC Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 310: LAMEA Precision Medicine Market Forecast, 2022-2032 (US$ million, AGR %)
  • Figure 311: COVID-19 Impact on LAMEA Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 312: COVID-19 Impact on LAMEA Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 313: COVID-19 Impact on LAMEA Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 314: COVID-19 Impact on LAMEA Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 315: LAMEA Precision Medicine Market Share Forecast, by Product& Services, 2022- 2032 (US$ Mn)
  • Figure 316: LAMEA Precision Medicine Market Share Forecast, by Product& Services, 2022, 2027 and 2032 (%)
  • Figure 317: LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 318: LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 319: LAMEA Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 320: LAMEA Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 321: LAMEA Precision Medicine Market Share Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 322: LAMEA Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 323: LAMEA Precision Medicine Market Share Forecast, by Country, 2022- 2032 (US$ Mn)
  • Figure 324: LAMEA Precision Medicine Market Share Forecast by Country, 2022, 2027, 2032 (%)
  • Figure 325: Brazil Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 326: Brazil Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 327: Brazil Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 328: Brazil Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 329: Brazil Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 330: Brazil Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 331: Brazil Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 332: Brazil Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 333: COVID-19 Impact on Brazil Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 334: COVID-19 Impact on Brazil Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 335: COVID-19 Impact on Brazil Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 336: COVID-19 Impact on Brazil Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 337: Mexico Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 338: Mexico Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 339: Mexico Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 340: Mexico Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 341: Mexico Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 342: Mexico Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 343: Mexico Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 344: Mexico Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 345: COVID-19 Impact on Mexico Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 346: COVID-19 Impact on Mexico Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 347: COVID-19 Impact on Mexico Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 348: COVID-19 Impact on Mexico Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 349: Saudi Arabia Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 350: Saudi Arabia Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 351: Saudi Arabia Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 352: Saudi Arabia Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 353: Saudi Arabia Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 354: Saudi Arabia Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 355: Saudi Arabia Precision Medicine Market Forecast, by End User, 2022- 2032 (US$ Mn)
  • Figure 356: Saudi Arabia Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 357: COVID-19 Impact on Saudi Arabia Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 358: COVID-19 Impact on Saudi Arabia Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 359: COVID-19 Impact on Saudi Arabia Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 360: COVID-19 Impact on Saudi Arabia Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 361: Rest of LAMEA Precision Medicine Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 362: Rest of LAMEA Precision Medicine Market Share Forecast, by product type, 2022, 2027, 2032 (%)
  • Figure 363: Rest of LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022- 2032 (US$ Mn)
  • Figure 364: Rest of LAMEA Precision Medicine Diagnostics Market Forecast, by Type, 2022, 2027, 2032 (%)
  • Figure 365: Rest of LAMEA Precision Medicine Market Forecast, by Application, 2022- 2032 (US$ Mn)
  • Figure 366: Rest of LAMEA Precision Medicine Market Forecast, by Application, 2022, 2027, 2032 (%)
  • Figure 367: Rest of LAMEA Precision Medicine Market Forecast, by End User 2022- 2032 (US$ Mn)
  • Figure 368: Rest of LAMEA Precision Medicine Market Share Forecast by End User, 2022, 2027, 2032 (%)
  • Figure 369: COVID-19 Impact on Rest of LAMEA Precision Medicine Market (USD million), 2022-2032: V-Shaped Recovery
  • Figure 370: COVID-19 Impact on Rest of LAMEA Precision Medicine Market (USD million), 2022-2032: U-Shaped Recovery
  • Figure 371: COVID-19 Impact on Rest of LAMEA Precision Medicine Market (USD million), 2022-2032: L-Shaped Recovery
  • Figure 372: COVID-19 Impact on Rest of LAMEA Precision Medicine Market (USD million), 2022-2032: W-Shaped Recovery
  • Figure 373: Pfizer Inc.: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 374: Pfizer Inc.: Segmental Revenue Shares 2021
  • Figure 375: Pfizer Inc.: Regional Revenue Shares 2021
  • Figure 376: Qiagen Inc: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 377: Qiagen Inc.: Segmental Revenue Shares 2021
  • Figure 378: Qiagen Inc.: Regional Revenue Shares 2021
  • Figure 379: Quest Diagnostics Inc: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 380: Quest Diagnostics Inc: Segmental Revenue Shares 2021
  • Figure 381: Agilent Technologies: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 382: Agilent Technologies: Segmental Revenue Shares 2021
  • Figure 383: Agilent Technologies: Regional Revenue Shares 2021
  • Figure 384: ILLUMINA: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 385: ILLUMINA: Segmental Revenue Shares 2021
  • Figure 386: ILLUMINA: Regional Revenue Shares 2021
  • Figure 387: Novartis AG: Net Revenue, 2017-2021 (US$ million, AGR %)
  • Figure 388: Novartis AG: Segmental Revenue Shares 2021
  • Figure 389: Novartis AG: Regional Revenue Shares 2021
  • Figure 390: BioMérieux SA: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 391: BioMérieux SA: Segmental Revenue Shares 2021
  • Figure 392: BioMérieux SA: Regional Revenue Shares 2021
  • Figure 393: Abbott Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 394: Abbott Laboratories: Segmental Revenue Shares 2021
  • Figure 395: Abbott Laboratories: Regional Revenue Shares 2021
  • Figure 396: F Hoffmann-La Roche AG: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 397: F Hoffmann-La Roche AG: Segmental Revenue Shares 2021
  • Figure 398: F Hoffmann-La Roche AG: Regional Revenue Shares 2021
  • Figure 399: Eli Lilly & Company: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 400: Eli Lilly & Company: Regional Revenue Shares 2021
  • Figure 401: GlaxoSmithKline Plc: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 402: GlaxoSmithKline Plc: Segmental Revenue Shares 2021
  • Figure 403: GlaxoSmithKline Plc: Regional Revenue Shares 2021
  • Figure 404: AstraZeneca plc: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 405: AstraZeneca plc: Segmental Revenue Shares 2021
  • Figure 406: AstraZeneca plc: Regional Revenue Shares 2021
  • Figure 407: Thermo Fischer Scientific Inc.: Net Revenue, 2016-2020 (US$ million, AGR%)
  • Figure 408: Thermo Fischer Scientific Inc.,:: Segmental Revenue Shares 2021
  • Figure 409: Thermo Fischer Scientific Inc.,:: Regional Revenue Shares 2021
  • Figure 410: Myriad Genetics Inc: Net Revenue, 2017-2021 (US$ million, AGR%)
  • Figure 411: Myriad Genetics Inc: Segmental Revenue Shares 2021

List of Companies Profiled in the report:

  • Abbott Laboratories
  • Abnova Corporation
  • Agilent Technologies
  • AstraZeneca
  • BioMérieux SA
  • Eli Lilly & Company
  • F Hoffmann-La Roche AG
  • GlaxoSmithKline Plc
  • Illumina
  • Myriad Genetics Inc.
  • Novartis AG
  • Pfizer Inc
  • Qiagen Inc.
  • Quest Diagnostics Inc.
  • Thermo Fisher Scientific, Inc.
  • List of Other Notable Players
  • 20/20 Gene Systems
  • Abbott Molecular
  • Affymetrix
  • Agilent (Dako)
  • Ambry Genetics
  • Amgen
  • Arca biopharma
  • Arno
  • Astellas Pharma
  • AstraZeneca
  • Asuragen
  • Bayer
  • Biomonitor
  • Boehringer Ingelheim
  • Brain Resource Company
  • Bristol-Myers Squibb
  • Cancer Research UK
  • CancerGuide Diagnostics
  • Caprion Proteomics
  • Caris Life Sciences
  • Celera (acquired by Quest Diagnostics)
  • Celgene
  • Cepheid
  • ChemGenex Pharmaceuticals
  • Clarient
  • Clinical Reference Laboratory
  • Clovis
  • College of American Pathology (CAP)
  • CompanDx
  • Crescendo Bioscience
  • Curidium Medica
  • Dako (Agilent)
  • Deloitte
  • DiagnoCure
  • Dx assays
  • DxS
  • Eli Lilly
  • Endocyte
  • European Medicines Agency (EMA)
  • Exosome Diagnostics
  • Ferring
  • Flagship Biosciences
  • FlowMetric Diagnostics
  • Foundation Medical
  • Foundation Medicine
  • Genentech
  • Genfit
  • Genia Technologies
  • Genmab
  • GenMark Diagnostics
  • Gilead Sciences
  • GlaxoSmithKline
  • GSK
  • Hexie Health
  • HistologiX
  • Idera
  • ImmunoGen
  • Incyte
  • InDex Pharmaceuticals
  • IntegraGen
  • Inverness Medical Innovations (now known as Alere)
  • Invivoscribe Technologies
  • Ipsen
  • Ipsogen
  • IQuum
  • Janssen Pharmaceutical
  • Kimball Genetics (a division of LabCorp)
  • Kunlun Health Insurance
  • Lab Corp
  • Lab21
  • Laboratory for Personalized Molecular Medicine
  • Leica
  • Leica Biosystems
  • Leica Micosystems
  • Life Technologies
  • Medical Research Council
  • Medicare
  • MedImmune (AstraZeneca)
  • Merck
  • Merck Serono
  • MolecularMD
  • Monogram Biosciences
  • Myriad RBM
  • Nanosphere
  • Nanostring
  • NanoString Technologies
  • National Health Insurance (NHI) (South Korea)
  • NIH
  • Northern Institute for Cancer Research
  • Novartis
  • Oxford BioTherapeutics (earlier Oxford Genome Sciences)
  • Pacific Diagnostics Clinical Laboratory (ResearchDx)
  • Pfizer
  • PICC Health Insurance
  • Ping An Insurance Group
  • Prionics
  • Progenika Biopharma
  • Prometheus
  • Protagen
  • Protagen Diagnostics
  • Quintiles
  • Quintiles Transnational Corporation
  • Randox Pharma Services
  • ResearchDx
  • Resonance Health
  • Resonance Health Analysis Services
  • RiboMed Biotechnologies
  • Rule-Based Medicine
  • Saladax Biomedical
  • ServizioSanitarioNazionale (SSN)
  • Siemens
  • Siemens Healthcare
  • Signal Genetics
  • Sirius Genomics
  • Sistema Único de Saúde (SUS)
  • Skyline Diagnostics
  • Solvay Innogenetics
  • Takeda's Millennium unit
  • Target Discovery
  • TcLand Expression
  • TESARO
  • The Association of British Pharmaceutical Industries
  • The Food and Drug Administration (FDA)
  • The Haute Autorité de santé (HAS)
  • The National Institute for Health and Care Excellence (NICE)
  • Theranostics (NZ)
  • Theranostics Health
  • Third Wave Technologies (Hologic)
  • TIB MolBiol
  • Tocagen
  • Tragara Pharmaceuticals
  • Transgenomic
  • TRICARE
  • TrimGen Corporation
  • Tufts Centre for the Study of Drug Development
  • Unilabs
  • University of Newcastle
  • Ventana Medical Systems (a subsidiary of Roche)
  • ViiV Healthcare
  • Weisenthal Cancer Group

List of Associations Mentioned in the Report:

  • AACR: American Association of Cancer Research
  • AAMRI: Association of Australian Medical Research Institutes
  • ACRG: Asian cancer Research Group
  • Centers for Medicare and Medicaid Services (CMS)
  • Centre for Drug Evaluation and Research (CDER)
  • CEPS: Economic and Public Health Evaluation Committee
  • European Medical Agency (EMA)
  • Food and Drug Administration (FDA)
  • French National Authority for Health
  • GENE: Genomics Expert Network for enterprises
  • Genomics Expert Network for enterprises (GENE)
  • Global Cancer Observatory (GLOBOCAN)
  • ICMR: Indian Council of Medical Research
  • INCA: Brazilian National Cancer Institute
  • International Agency Tor Research on Cancer (IARC)
  • Joint United Nations Programme on HIV and AIDS (UNAIDS)
  • LSCDD: Lilly Singapore Centre for Drug Discovery
  • Macmillan Cancer Support
  • MDCG: Medical Device Co-ordination Group
  • Medical Device Co-ordination Group (MDCG)
  • NAACLS: National Accrediting Agency report for Clinical Laboratory sciences
  • National Cancer institute (NCI)
  • National Institute of Cancer (INCa)
  • NCBI: National Centre for Biotechnology Information
  • PMDA: Pharmaceuticals and Medical Devices Agency
  • PMWG: Personalized Medicine working Group
  • SEAP: Spanish society of Anatomic Pathology
  • SEOM: Spanish Society of Medical Oncology
  • Spanish National R&D Plan
  • Spanish Society of Medical Oncology (SEOM)
  • U.S. Department of Agriculture (USDA)
  • World Cancer Research Fund
  • World health Organization (WHO)